These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1238 related articles for article (PubMed ID: 19401307)

  • 21. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
    Cohen AT; Nandini B; Wills JO; Ota S
    Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN.
    Schellong SM; Haas S; Greinacher A; Schwanebeck U; Sieder C; Abletshauser C; Bramlage P; Riess H
    Expert Opin Pharmacother; 2010 Dec; 11(18):2953-61. PubMed ID: 20950224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding and venous thromboembolism arising in acutely ill hospitalized medical patients. Findings from the Spanish national discharge database.
    Guijarro R; San Roman C; Arcelus JI; Montes-Santiago J; Gómez-Huelgas R; Gallardo P; Monreal M
    Eur J Intern Med; 2014 Feb; 25(2):137-41. PubMed ID: 24200547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
    Stinnett JM; Pendleton R; Skordos L; Wheeler M; Rodgers GM
    Am J Hematol; 2005 Mar; 78(3):167-72. PubMed ID: 15726600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis.
    Bauman JA; Church E; Halpern CH; Danish SF; Zaghloul KA; Jaggi JL; Stein SC; Baltuch GH
    Neurosurgery; 2009 Aug; 65(2):276-80; discussion 280. PubMed ID: 19625905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
    Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
    Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous thromboembolism prophylaxis conversion in nonsurgical inpatients.
    Carroll DN; Hudson EB
    Ann Pharmacother; 2003 Sep; 37(9):1194-6. PubMed ID: 12921498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury.
    Scudday T; Brasel K; Webb T; Codner P; Somberg L; Weigelt J; Herrmann D; Peppard W
    J Am Coll Surg; 2011 Jul; 213(1):148-53; discussion 153-4. PubMed ID: 21459632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification and utilisation of thrombo-embolism prophylaxis in a medical-surgical ICU: a hospital-based study.
    Ansari K; Dalal K; Patel M
    J Indian Med Assoc; 2007 Sep; 105(9):536, 538, 540 passim. PubMed ID: 18338482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of venous thromboembolism prophylaxis in morbidly obese patients undergoing gastric bypass surgery.
    Cotter SA; Cantrell W; Fisher B; Shopnick R
    Obes Surg; 2005 Oct; 15(9):1316-20. PubMed ID: 16259895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials.
    Eikelboom JW; Quinlan DJ; O'Donnell M
    Circulation; 2009 Nov; 120(20):2006-11. PubMed ID: 19884469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.
    Khaldi A; Helo N; Schneck MJ; Origitano TC
    J Neurosurg; 2011 Jan; 114(1):40-6. PubMed ID: 20815694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism prophylaxis in hospitalized heart failure patients.
    Jois-Bilowich P; Michota F; Bartholomew JR; Glauser J; Diercks D; Weber J; Fonarow GC; Emerman CL; Peacock WF;
    J Card Fail; 2008 Mar; 14(2):127-32. PubMed ID: 18325459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism: application and effectiveness of the American College of Chest Physicians 2001 guidelines for prophylaxis.
    Steier KJ; Singh G; Ullah A; Maneja J; Ha RS; Khan F
    J Am Osteopath Assoc; 2006 Jul; 106(7):388-95. PubMed ID: 16912336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits.
    Dudley RR; Aziz I; Bonnici A; Saluja RS; Lamoureux J; Kalmovitch B; Gursahaney A; Razek T; Maleki M; Marcoux J
    J Neurotrauma; 2010 Dec; 27(12):2165-72. PubMed ID: 20939698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
    Petersen LJ
    Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.